Abstract
The genetic basis of hepatocellular carcinoma (HCC) has not yet been fully understood. Although various methods have been developed to detect differentially expressed genes in malignant diseases, efficient analysis from clinical specimens is generally difficult to perform due to the requirement of a large amount of samples. In the present study, we analysed differentially expressed genes with a small amount of human HCC samples using suppression subtractive hybridization (SSH). Total RNA were obtained from the hepatitis C virus-associated HCC and adjacent non-HCC liver tissues. cDNA was synthesized using modified RT-PCR, and then tester cDNA was ligated with 2 different kinds of adaptors and hybridized with an excess amount of driver cDNA. Tester specific cDNA was obtained by suppression PCR and the final PCR product was subcloned and sequenced. We identified 7 known genes (focal adhesion kinase, deleted in colon cancer, guanine binding inhibitory protein α, glutamine synthetase, ornithine aminotransferase, M130, and pepsinogen C) and 2 previously unknown genes as being overexpressed in HCC, and 1 gene (decorin) as suppressed in HCC. Quantitative analysis of gene expression using quantitative RT-PCR demonstrated the differential expression of these genes in the original and other HCC samples. These findings demonstrated that it is possible to identify the previously unknown, differential gene expression from a small amount of clinical samples. Information about such alterations in gene expression could be useful for elucidating the genetic events in HCC pathogenesis, developing the new diagnosic markers, or determining novel therapeutic targets. © 2001 Cancer Research Campaign www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D and Levine AJ (1999) Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 96: 6745–6750
Balbin M and Lopez-Otin C (1996) Hormonal regulation of the human pepsinogen C gene in breast cancer cells. Identification of a cis-acting element mediating its induction by androgens, glucocorticoids, and progesterone. J Biol Chem 271: 15175–15181
Bratthauer GL and Fanning TG (1992) Active LINE-1 retrotransposons in human testicular cancer. Oncogene 7: 507–510
Chomczynski P, Sacchi N, Siebert PD, Lukyanov SA, Sverdlov ED and Berg DE (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159
Christa L, Simon MT, Flinois JP, Gebhardt R, Brechot C and Lasserre C (1994) Overexpression of glutamine synthetase in human primary liver cancer. Gastroenterology 106: 1312–1320
Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED and Siebert PD (1996) Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 93: 6025–6030
Diez-Itza I, Merino AM, Tolivia J, Vizoso F, Sanchez LM and Lopez-Otin C (1993) Expression of pepsinogen C in human breast tumours and correlation with clinicopathologic parameters. Br J Cancer 68: 637–640
Dragani TA, Manenti G, Della Porta G, Gattoni-Celli S and Weinstein IB (1986) Expression of retroviral sequences and oncogenes in murine hepatocellular tumors. Cancer Res 46: 1915–1919
el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825
Endege WO, Steinmann KE, Boardman LA, Thibodeau SN and Schlegel R (1999) Representative cDNA libraries and their utility in gene expression profiling. Biotechniques 26: 542–548, 550
Fazeli A, Dickinson SL, Hermiston ML, Tighe RV, Steen RG, Small CG, Stoeckli ET, Keino-Masu K, Masu M, Rayburn H, Simons J, Bronson RT, Gordon JI, Tessier-Lavigne M and Weinberg RA (1997) Phenotype of mice lacking functional Deleted in colorectal cancer (DCC) gene. Nature 386: 796–804
Frank S, von Specht BU, Farthmann EH and Hirsch T (1998) Identification of genes involved in human mesothelial cancer progression using a modified differential display technique. Cancer Lett 123: 7–14
Frisch SM, Vuori K, Ruoslahti E and Chan-Hui PY (1996) Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134: 793–799
Gotley DC, Reeder JA, Fawcett J, Walsh MD, Bates P, Simmons DL and Antalis TM (1996) The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases. Oncogene 13: 787–795
Khan J, Simon R, Bittner M, Chen Y, Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM and Meltzer PS (1998) Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 58: 5009–5013
Kishi K, Kinoshita Y, Matsushima Y, Okada A, Maekawa T, Kawanami C, Watanabe N and Chiba T (1997) Pepsinogen C gene product is a possible growth factor during gastric mucosal healing. Biochem Biophys Res Commun 238: 17–20
Konishi N, Nakaoka S, Matsumoto K, Nakamura M, Kuwashima S, Hiasa Y, Cho M, Uemura H and Hirao Y (1999) Expression of pepsinogen II with androgen and estrogen receptors in human prostate carcinoma. Pathol Int 49: 203–207
Kornberg LJ (1998) Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head Neck 20: 745–752
Kuang WW, Thompson DA, Hoch RV, Weigel RJ, Siebert PD, Lukyanov SA, Sverdlov ED and Berg DE (1998) Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res 26: 1116–1123
Liang P, Averboukh L, Keyomarsi K, Sager R and Pardee AB (1992) Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res 52: 6966–6968
Matz M, Shagin D, Bogdanova E, Britanova O, Lukyanov S, Diatchenko L and Chenchik A (1999) Amplification of cDNA ends based on template-switching effect and step-out PCR. Nucleic Acids Res 27: 1558–1560
Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS and Bredesen DE (1998) The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395: 801–804
Nagasue N, Yu L, Yukaya H, Kohno H and Nakamura T (1995) Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: impact on intrahepatic recurrence after hepatic resection. Br J Surg 82: 542–547
Osada T, Sakamoto M, Nagawa H, Yamamoto J, Matsuno Y, Iwamatsu A, Muto T and Hirohashi S (1999) Acquisition of glutamine synthetase expression in human hepatocarcinogenesis: relation to disease recurrence and possible regulation by ubiquitin-dependent proteolysis. Cancer 85: 819–831
Owens LV, Xu L, Dent GA, Yang X, Sturge GC, Craven RJ and Cance WG (1996) Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol 3: 100–105
Plasterk RH, Izsvak Z and Ivics Z (1999) Resident aliens: the Tc1/mariner superfamily of transposable elements. Trends Genet 15: 326–332
Ritter M, Buechler C, Langmann T and Schmitz G (1999) Genomic organization and chromosomal localization of the human CD163 (M130) gene: a member of the scavenger receptor cysteine-rich superfamily. Biochem Biophys Res Commun 260: 466–474
Robertson HM, Zumpano KL, Lohe AR and Hartl DL (1996) Reconstructing the ancient mariners of humans. Nat Genet 12: 360–361
Santra M, Skorski T, Calabretta B, Lattime EC and Iozzo RV (1995) e novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc Natl Acad Sci USA 92: 7016–7020
Sherlock S and Dooley J (1997). Disease of the liver and biliary system, Blackwell Science: Oxford
Skowronski J, Fanning TG and Singer MF (1988) Unit-length line-1 transcripts in human teratocarcinoma cells. Mol Cell Biol 8: 1385–1397
Stander M, Naumann U, Wick W and Weller M (1999) Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res 296: 221–227
Stubbs AP, Abel PD, Golding M, Bhangal G, Wang Q, Waxman J, Stamp GW and Lalani EN (1999) Differentially expressed genes in hormone refractory prostate cancer: association with chromosomal regions involved with genetic aberrations. Am J Pathol 154: 1335–1343
Tremblay L, Hauck W, Aprikian AG, Begin LR, Chapdelaine A and Chevalier S (1996) Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma. Int J Cancer 68: 164–171
Vasmatzis G, Essand M, Brinkmann U, Lee B and Pastan I (1998) Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis. Proc Natl Acad Sci USA 95: 300–304
Velculescu VE, Zhang L, Vogelstein B and Kinzler KW (1995) Serial analysis of gene expression. Science 270: 484–487
von Stein OD, Thies WG and Hofmann M (1997) A high throughput screening for rarely transcribed differentially expressed genes. Nucleic Acids Res 25: 2598–2602
Weiner TM, Liu ET, Craven RJ and Cance WG (1993) Expression of focal adhesion kinase gene and invasive cancer. Lancet 342: 1024–1025
Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ, Siebert PD, Lukyanov SA, Sverdlov ED and Berg DE (1997) The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 22: 176–181
Zachar V, Thomas RA, Goustin AS, Siebert PD, Lukyanov SA, Sverdlov ED and Berg DE (1993) Absolute quantification of target DNA: a simple competitive PCR for efficient analysis of multiple samples. Nucleic Acids Res 21: 2017–2018
Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B and Kinzler KW (1997) Gene expression profiles in normal and cancer cells. Science 276: 1268–1272
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Miyasaka, Y., Enomoto, N., Nagayama, K. et al. Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization. Br J Cancer 85, 228–234 (2001). https://doi.org/10.1054/bjoc.2001.1901
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2001.1901
Keywords
This article is cited by
-
Subtractive hybridization-assisted screening and characterization of genes involved in the rice-Magnaporthe oryzae interaction
Phytopathology Research (2019)
-
Pepsinogen C expression, regulation and its relationship with cancer
Cancer Cell International (2017)
-
High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma
Tumor Biology (2016)
-
Small nucleolar RNA 113–1 suppresses tumorigenesis in hepatocellular carcinoma
Molecular Cancer (2014)
-
Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers
Functional & Integrative Genomics (2011)
